Prevention of Vibrio parahaemolyticus infection in pacific white shrimp (Penaeus vannamei) using oral Moringa oleifera leaf powder as an alternative to antibiotics Authors: Sri Nuryati, Dika Nur Setiyawan, Munti Yuhana, Muhamad Gustilatov Published: 2026 ABSTRACT This study investigates the immunostimulatory effects of Moringa oleifera leaf powder on Pacific white shrimp (Penaeus vannamei) challenged with Vibrio parahaemolyticus. Shrimp were orally administered Moringa powder at varying doses (0.5, 0.75, and 1 g/kg) for 30 days before being exposed to V. parahaemolyticus (10⁷ CFU/mL). Post-challenge, shrimp fed Moringa-supplemented diets exhibited a significantly higher survival rate and enhanced non-specific immune responses compared to the control group. Among the tested doses, 0.5 g/kg was the most effective in improving shrimp immunity and growth performance. Gene expression analysis further confirmed the immunomodulatory effects of Moringa supplementation, with significant upregulation of key immune-related genes, including lipopolysaccharide and beta-1,3-glucan binding protein (LGBP), serine protease (SP), and peroxinectin (PE). These findings indicate an improved immune defense mechanism in shrimp. The presence of bioactive compounds such as lectins, flavonoids, and phenolic acids in Moringa is likely responsible for its immunostimulatory properties. Overall, this study highlights Moringa leaf powder as a promising natural immunostimulant and a potential alternative to antibiotics for disease prevention in shrimp aquaculture. The optimal dietary inclusion level for enhanced immunity and survival was determined to be 0.5 g/kg. Further research is recommended to explore the long-term effects and underlying molecular mechanisms of Moringa supplementation in shrimp health management. Introduction Pacific white shrimp (Penaeus vannamei) is a high-value aquaculture commodity with significant economic importance. In 2022, global shrimp production reached 6.8 million tons [1]. The main producers of white shrimp are China, Ecuador, India, Vietnam, and Indonesia, collectively accounting for approximately 74 % of global production. China leads in total farmed shrimp output, while Ecuador, India, Vietnam, and Indonesia remain key players in both production and international export markets [1]. Among them, India and Vietnam are major white shrimp producers, driven by the rapid expansion of intensive farming, strong export demand, and government-supported disease management and sustainability programs that enhance productivity and global competitiveness [2]. Similarly, Indonesia, one of the world’s leading shrimp exporters, contributed approximately 241,173 tons of shrimp valued at USD 2.16 billion in 2022, representing 34.57 % of the country’s total seafood export value [3]. However, the national shrimp production during the same year remained relatively low, reaching only 1.10 million tons [4]. Compared to black tiger shrimp (Penaeus monodon), P. vannamei offers several advantages, including a shorter production cycle, higher annual profitability, and relatively better disease resistance [5]. Despite its economic importance, shrimp farming continues to suffer substantial losses due to both viral and bacterial diseases. Among these, vibriosis caused by various Vibrio species remains one of the most significant threats to shrimp aquaculture [6]. This disease has been reported in several countries, including Mexico, the Philippines, China, and Thailand, and is estimated to have caused economic losses ranging from USD 1.3 to 11 billion in Asia between 2010 and 2016 [7]. Vibriosis is primarily associated with pathogenic species such as Vibrio alginolyticus, V. harveyi, V. splendidus, and V. parahaemolyticus [8]. These pathogens can infect shrimp at all life stages, leading to mass mortality and severely affecting growth performance [9]. In the Asian region, Vibrio species have been implicated in several major disease outbreaks, including vibriosis, acute hepatopancreatic necrosis disease (AHPND), luminous vibriosis, white feces disease (WFD), and translucent post-larvae disease (TPD), resulting in high mortality and substantial economic losses for key shrimp-producing countries [[10], [11]]. Furthermore, farmed shrimp can also acquire other Vibrio-associated diseases such as Zoea-2 Syndrome, Seagull Syndrome (SGS), Mysis Mold Syndrome, and Bolitas Syndrome, which collectively contribute to production losses and health deterioration in cultured shrimp populations [12]. Recent studies have also revealed that Vibrio species are dominant members of bacterial communities in shrimp culture systems, suggesting that their abundance and composition in pond environments are closely linked to disease emergence and shrimp health [13]. Among these pathogens, V. parahaemolyticus is recognized as a highly virulent strain capable of causing up to 80 % mortality in white shrimp (Penaeus vannamei) due to the presence of PirA and PirB toxins, which are the main virulence factors associated with AHPND [[14], [15], [16]]. The occurrence of AHPND-causing V. parahaemolyticus has also been confirmed in Indonesia, posing a serious threat to the long-term sustainability of shrimp aquaculture in the region [[17], [18]]. Various strategies, including vaccination and antibiotic administration, have been implemented to control vibriosis. However, vaccines are costly and typically target specific pathogens [19]. The excessive use of antibiotics has also raised concerns regarding antimicrobial resistance (AMR) and residual contamination in shrimp products [20]. As a result, there is growing interest in alternative disease control strategies, such as immunostimulants, which enhance the non-specific immune response of aquatic organisms [21]. Moringa oleifera (commonly known as the drumstick tree) has gained attention as a potential immunostimulant due to its rich nutritional and bioactive compound content [22]. Moringa leaves, in particular, are widely utilized because they grow rapidly and contain essential amino acids, vitamins (A, B, C), calcium, and iron [23]. Additionally, moringa leaves are abundant in phytochemicals, including flavonoids, alkaloids, tannins, and polyphenols, which exhibit antimicrobial, antioxidant, and immunostimulatory properties [[24], [25]]. A study by Kenconojati et al. (2023) [26], demonstrated that moringa leaf extract contains 71.9 mg/g flavonoids, 3 mg/g alkaloids, 24.7 mg/g tannins, and 44.4 mg/g saponins, which contribute to its therapeutic effects. Several studies have explored the application of M. oleifera in disease prevention. Abidin et al. (2021) [27], reported that a 2.5 g/L dose of moringa leaf extract enhanced non-specific immune responses, including total haemocyte count and phenoloxidase activity, in P. vannamei challenged with V. alginolyticus. Furthermore, Abidin et al. (2022) [28], found that moringa extract effectively boosted the immune response of shrimp infected with V. parahaemolyticus. A study by Kenconojati et al. (2023) [26], also demonstrated that a 1 g dose of moringa extract produced an inhibition zone of 22.92 mm against V. parahaemolyticus, indicating its strong antibacterial potential. Given the promising immunostimulatory and antimicrobial properties of M. oleifera, this study aims to evaluate the efficacy of moringa leaf powder in preventing vibriosis caused by V. parahaemolyticus in P. vannamei. The findings of this research could contribute to the development of sustainable and antibiotic-free disease prevention strategies in shrimp aquaculture. Material and methods Experimental design The study was conducted using a completely randomized design (CRD) with five treatment groups, each replicated four times. The treatments included a negative control (K-), where shrimp were neither supplemented with moringa leaf powder nor challenged with V. parahaemolyticus, and a positive control (K+), where shrimp were challenged with V. parahaemolyticus without moringa supplementation. Three experimental groups received moringa leaf powder through feed supplementation at different concentrations: 0.5 g/kg (M0.5), 0.75 g/kg (M0.75), and 1 g/kg (M1), followed by V. parahaemolyticus infection. Location of the study The experiment was conducted at the Health of Aquatic Organisms Laboratory, Department of Aquaculture, Faculty of Fisheries and Marine Science, IPB University, Bogor, Indonesia (6°33′ S, 106°43′ E). The experimental location and site are presented in Fig. 1.Fig. 1Location of the experimental site. (A) Map of Indonesia showing the position of West Java Province. (B) Map of Bogor Regency indicating the Dramaga area where IPB University is located. (C) Satellite image of the Department of Aquaculture, Faculty of Fisheries and Marine Science, IPB University, showing the Fish Health and Environmental Laboratory (red circle) as the research site. Source: Google Earth (accessed October 31, 2025).Fig 1 Location of the experimental site. (A) Map of Indonesia showing the position of West Java Province. (B) Map of Bogor Regency indicating the Dramaga area where IPB University is located. (C) Satellite image of the Department of Aquaculture, Faculty of Fisheries and Marine Science, IPB University, showing the Fish Health and Environmental Laboratory (red circle) as the research site. Source: Google Earth (accessed October 31, 2025). Shrimp preparation The test shrimp used in this study were Penaus vannamei specific pathogen free (SPF) certified obtained from the local hatchery in Serang Regency, Banten Province, Indonesia. The shrimp were obtained at the post-larvae (PL) 8 stage and were reared for 40 days until they reached the appropriate size for the experiment. Once they reached the desired size, the shrimp were transferred to fiber tanks and acclimatized for seven days. During acclimatization, the shrimp were fed five times daily at 06:00, 10:00, 14:00, 18:00, and 22:00 [29]. Before the experimental treatments, an initial sampling was conducted to measure the shrimp's body weight. Bacteria preparation The V. parahaemolyticus bacteria were obtained from the Laboratoty of Aquatic Organism Health, Department of Aquaculture, IPB University. The bacteria were cultured on Thiosulfate Citrate Bile Salt Sucrose Agar (TCBS) medium supplemented with rifampicin (50 μg/mL) and subjected to Koch’s postulates [30]. Shrimp used for Koch’s postulates were observed for symptom development, after which the hepatopancreas was streaked onto TCBS medium containing antibiotics for bacterial isolation. The isolated V. parahaemolyticus was then grown in chromogenic media and subjected to PCR using a toxR kit to confirm the presence of the toxR gene, verifying its identity as V. parahaemolyticus [31]. Additionally, PCR was performed using an AP4 kit to detect the presence of pirA and pirB toxin genes, which are associated with Acute Hepatopancreatic Necrosis Disease (AHPND) [32]. The grown bacterial colonies were collected using an inoculation loop and inoculated into Sea Water Complete (SWC) Broth. The bacteria were then incubated in a shaker at 160 rpm for 18–24 h until they reached the desired growth phase for harvesting. After incubation, the bacterial suspension was diluted to the appropriate concentration for the challenge test. Moringa leaf and test feed preparation The Moringa leaf powder used in this study was obtained from local store, Blora Regency, Central Java Province, Indonesia. The powder was then tested for its inhibition zone to evaluate its antibacterial activity against V. parahaemolyticus. The experimental feed used was commercial pellet feed (Fengli, Matahari Sakti, Indonesia) with a protein content of approximately 40 %. Before use, the feed was supplemented with Moringa leaf powder using a coating method. The different concentrations of Moringa leaf powder (0.5 %, 1 %, and 1.5 %) were prepared by first dissolving the appropriate amount of Moringa leaf powder in sterile distilled water at a volume of 300 mL per kg of feed. Specifically, 5 g, 10 g, and 15 g of Moringa leaf powder were each mixed with 300 mL of water, respectively, and then thoroughly sprayed onto 1 kg of commercial shrimp feed. The feed was then air-dried at room temperature for 24 h and stored at 4 °C until use in the feeding trial. Shrimp maintenance and challenge test Pacific white shrimp with an average weight of 1.18±0.02 g were reared for 30 days in glass aquariums measuring 60×30×40 cm3, with a water height of 33 cm (working volume of 60 L). The experiment was conducted at the Laboratory of Health of Aquatic Organisms, Department of Aquaculture, Faculty of Fisheries and Marine Sciences, IPB University, located in Bogor, West Java, Indonesia. The shrimp were fed according to the treatment groups from day 1 to day 30. The feeding frequency was five times a day at 06:00, 10:00, 14:00, 18:00, and 22:00 WIB, with a feed rate of 10 % of the shrimp biomass [33]. Weight sampling was conducted three times: at the beginning of the rearing period when the shrimp were stocked into the fiber tanks, on day 15 of rearing, and at the end of the rearing period. Water quality was maintained using filters and filter cotton, with a 50 % water exchange every seven days. After the rearing period, the shrimp were subjected to a challenge test with V. parahaemolyticus. The shrimp were injected intramuscularly with 0.1 mL per individual of a solution containing V. parahaemolyticus at a concentration of 10⁷ CFU mL⁻¹ (Lethal Dose 50 % (LD50), according to Reed and Muench (1938) [34]). Meanwhile, the negative control shrimp were injected with 0.1 mL per individual of phosphate-buffered saline (PBS). The challenge test was conducted for 14 days, during which the shrimp were fed regularly, and no water exchange was performed. Water quality parameters, including temperature, pH, dissolved oxygen (DO), salinity, and total ammonia nitrogen (TAN), were measured in the Environmental Laboratory, Department of Aquaculture, Bogor Agricultural University, following APHA (2005) [35], standards. Daily measurements were conducted, except for TAN, which was analyzed at the beginning and end of the rearing period. In situ methods were used for temperature, pH, DO, and salinity, while TAN was analyzed ex situ. Salinity ranged from 27 to 28 ppt initially and 26–28 ppt at the end, temperature varied from 25.6 to 27.4 °C to 26.0–27.5 °C, DO remained above 3 mg/L (6.0–6.9 mg/L initially, 5.6–6.8 mg/L at the end), pH ranged from 7.40 to 7.84 to 7.30–7.72, and TAN levels were 0.004–0.079 mg/mL initially and 0.040–0.101 mg/mL at the end. Parameters Phytochemical and inhibition zone test of moringa leaf powder The phytochemical analysis of Moringa leaf powder was conducted at the IPB Center for Biopharmaceutical Studies Laboratory [36]. Following this, an inhibition zone test against V. parahaemolyticus was performed using Moringa leaf powder at concentrations of 50 %, 75 %, and 100 % per gram. The powder was dissolved in distilled water according to each concentration at a ratio of 10:1 (10 mL water per 1 g powder), and sterile paper discs were soaked in the solution. V. parahaemolyticus was evenly cultured on SWC (Sea Water Complete) agar, and the soaked discs, along with the control, were placed on the medium. After 24 h of incubation, the inhibition zones were measured. Shrimp survival and relative percent survival The survival rate (SR) of shrimp was observed from day 0 to day 30 of the experiment and calculated using the formula SR ( %) = (Nt/N0)×100, where Nt​ is the number of surviving shrimp at the end of the experiment, and N0​ is the initial number of shrimp. Additionally, daily mortality was recorded for 30 days, and relative percent survival (RPS) was determined using the equation RPS ( %) = (1−(Mn/M0))×100, where Mn ​represents the mortality percentage in the treatment group, and M0 represents the mortality percentage in the control group. Shrimp immune response Total Hemocyte Count (THC) was determined by mixing hemolymph with anticoagulant (1:2), homogenizing, and loading 20 µL onto a hemocytometer for microscopic counting at 100× magnification. THC was calculated using the formula by Wang and Chen (2006) [37], Phenoloxidase (PO) activity was measured by recording dopachrome formation from l-DOPA via spectrophotometry. Hemolymph samples were collected before treatment, before challenge, and on days 1, 3, 5, 7, and 14 post-challenge. Samples were centrifuged at 3500 rpm for 10 min at 4 °C, and the pellet was resuspended in cacodylate-citrate buffer, incubated with trypsin, and reacted with l-DOPA. Optical density (OD) was measured at 490 nm [38]. Respiratory Burst (RB) was assessed by NBT reduction as a superoxide anion indicator. Samples were incubated, centrifuged, reacted with NBT at room temperature, and further processed with methanol, KOH, and DMSO before OD measurement at 630 nm) [39]. Phagocytic Activity (PA) was analyzed using hemolymph mixed with Staphylococcus aureus suspension, incubated at 28 °C, and prepared as thin smears. Samples were fixed with methanol, stained with Giemsa, and observed microscopically. PA was calculated using Xian et al. (2010) [40], formula. Shrimp growth performance The growth rate (GR) during the rearing period is calculated using the formula by Liu et al. (2019) [41]. GR ( %/day) = (Wt – W0) / t, where DGR represents the daily growth rate in percentage per day, Wt is the average shrimp weight at the end of the rearing period (g), W0 is the average shrimp weight at the beginning of the rearing period (g), and t is the duration of the rearing period (days). Meanwhile, the feed conversion ratio (FCR) of shrimp during rearing is calculated using the formula by Yang et al. (2015) [42] : FCR = F / (Bt – B0), where F is the total feed consumed during the rearing period (g), Bt is the shrimp biomass at the end of the treatment (g), and B0 is the shrimp biomass at the beginning of the treatment (g). Expression of immune-related genes in shrimp Shrimp RNA was extracted from the hepatopancreas using GeneZol™ (Geneaid, Taiwan) following the manufacturer’s instructions. Total RNA was analyzed with a Nanodrop 2000 (Thermo Scientific, USA) at 260 nm and 280 nm. cDNA synthesis was performed using the RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific, USA) for bacterial RNA and ReverTraAce® qPCR RT Mastermix with gDNA Remover (Toyobo, Japan) for shrimp RNA. Gene expression was then measured via real-time quantitative PCR (qPCR) using elongation factor 1α (EF-1α) as the reference gene. The synthesized cDNA could be immediately used for qPCR or stored at −20 °C. Shrimp immune-related gene expression was analyzed before the challenge test (H0), on day 1 post-challenge (H1-UT), and day 7 post-challenge (H7-UT). The target genes included Lipopolysaccharide and beta-1,3-glucan binding protein (LGBP), serine protease (SP), peroxinectin (PE), with elongation factor-1α (EF-1α) as the housekeeping gene [43]. qPCR amplification was performed in a 20 µL reaction containing 10 µL SYBR® FAST qPCR kit (KAPA, USA), 1.6 µL (0.8 µL each) of specific forward and reverse primers, 4 µL cDNA, and 4.4 µL NFW. The thermal cycling program included pre-denaturation at 95 °C for 10 min, followed by 40 cycles of denaturation (95 °C, 10 s), annealing (60 °C, 15 s), extension (72 °C, 15 s), and a final extension at 72 °C for 7 min. A melt-curve analysis confirmed single-product amplification, and real-time standard curves were prepared for each gene. Target gene mRNA levels were normalized to the housekeeping gene and expressed as relative levels compared to the control group. Primer sequences are listed in Table 1. Relative gene expression was evaluated using the 2−∆∆Ct method [44].Table 1Primers used in the analysis of gene expression of shrimp immunity.Table 1GeneSequencesFunctionReferencesLGBPF: CATGTCCAACTTCGCTTTCAGAR: ATCACCGCGTGGCATCTTGram-negative receptorCheng et al. (2005)PEF: TGGACCTCGCGGGAGATR: GACCGATAGCCACCATGCTTTransduction signalLiu et al. (2005)SPF: CGTCGTTAGGTTAAGTGCGTTCTR: TTTCAGCGCATTAAGACGTGTTAntimicrobial proteinPanigrahi et al. (2020)EF-1αF: CTGTGGTCTGGTTGGTGTTGR: TCAGATGGGTTCTTGGGTTCReference geneAlvarez-Ruiz et al. (2015) Table 1Primers used in the analysis of gene expression of shrimp immunity.Table 1GeneSequencesFunctionReferencesLGBPF: CATGTCCAACTTCGCTTTCAGAR: ATCACCGCGTGGCATCTTGram-negative receptorCheng et al. (2005)PEF: TGGACCTCGCGGGAGATR: GACCGATAGCCACCATGCTTTransduction signalLiu et al. (2005)SPF: CGTCGTTAGGTTAAGTGCGTTCTR: TTTCAGCGCATTAAGACGTGTTAntimicrobial proteinPanigrahi et al. (2020)EF-1αF: CTGTGGTCTGGTTGGTGTTGR: TCAGATGGGTTCTTGGGTTCReference geneAlvarez-Ruiz et al. (2015) Primers used in the analysis of gene expression of shrimp immunity. Data analyses The collected data were tabulated using Microsoft Excel 2016 and analyzed using one-way ANOVA in SPSS version 26. If significant differences were found, a post hoc test was conducted using Duncan's test with a 95 % confidence interval. Water quality parameters were analyzed descriptively. Results Phytochemical and inhibition zone test of moringa leaf powder Phytochemical analysis of Moringa leaf powder revealed the presence of flavonoids, tannins, and steroids. The inhibition zone test against V. parahaemolyticus at 50 %, 75 %, and 100 % concentrations per 1 g of Moringa leaf powder is presented in Table 2. The results showed inhibition zones of 11.00±1.13 mm (50 %), 12.41±0.49 mm (75 %), and 15.83±0.25 mm (100 %), with PBS as the control. The 100 % concentration exhibited the highest inhibition zone, significantly different (P < 0.05) from the 50 % and 75 % concentrations.Table 2Inhibition zone of V. parahaemolyticus with moringa leaf powder addition.Table 2TreatmentV. parahaemolyticus inhibition zone (mm)PBS0,00±0,0050 % Moringa leaf powder11,00±1,13a75 % Moringa leaf powder12,41±0,49a100 % Moringa leaf powder15,83±0,25bNote: Different superscript letters in the same row indicate significant differences between treatments (P < 0.05). The values presented are means ± standard deviation. Table 2Inhibition zone of V. parahaemolyticus with moringa leaf powder addition.Table 2TreatmentV. parahaemolyticus inhibition zone (mm)PBS0,00±0,0050 % Moringa leaf powder11,00±1,13a75 % Moringa leaf powder12,41±0,49a100 % Moringa leaf powder15,83±0,25bNote: Different superscript letters in the same row indicate significant differences between treatments (P < 0.05). The values presented are means ± standard deviation. Inhibition zone of V. parahaemolyticus with moringa leaf powder addition. Note: Different superscript letters in the same row indicate significant differences between treatments (P < 0.05). The values presented are means ± standard deviation. Shrimp survival and relative percent survival The shrimp survival, mortality, and relative percent survival (RPS) of white shrimp treated with Moringa leaf powder are presented in Table 3. The survival and mortality values after the challenge test showed a significant difference (P < 0.05) compared to the positive control but there is no significant difference from the negative control. Meanwhile, RPS among treatments showed no significant differences. These results indicate that Moringa leaf powder supplementation can enhance the survival rate (SR) and relative percent survival (RPS), and reduce mortality of P. vannamei during the rearing period and after the challenge test with V. parahaemolyticus.Table 3Survival rate and dan relative percent survival of shrimp fed with Moringa leaf powder and challenged with V. parahaemolyticus.Table 3TreatmentParametersSurvival ( %)Mortality ( %)RPS ( %)K-93,33±6,51b6,67±6,51a-K+44,33±10,26a53,33±10,69b-M0,586,67±6,51b13,33±6,51a76,00±12,00aM0,7580,33±7,00b20,00±7,00a64,00±12,00aM160,00±6,11b22,00±10,15a60,00±18,00aNote: Different superscript letters in the same row indicate significant differences between treatments (P < 0.05). The values presented are means ± standard deviation. Table 3Survival rate and dan relative percent survival of shrimp fed with Moringa leaf powder and challenged with V. parahaemolyticus.Table 3TreatmentParametersSurvival ( %)Mortality ( %)RPS ( %)K-93,33±6,51b6,67±6,51a-K+44,33±10,26a53,33±10,69b-M0,586,67±6,51b13,33±6,51a76,00±12,00aM0,7580,33±7,00b20,00±7,00a64,00±12,00aM160,00±6,11b22,00±10,15a60,00±18,00aNote: Different superscript letters in the same row indicate significant differences between treatments (P < 0.05). The values presented are means ± standard deviation. Survival rate and dan relative percent survival of shrimp fed with Moringa leaf powder and challenged with V. parahaemolyticus. Note: Different superscript letters in the same row indicate significant differences between treatments (P < 0.05). The values presented are means ± standard deviation. Shrimp Immune Response After 30 days of Moringa leaf powder administration (H30), THC, PO, RB, and PA levels significantly increased (P < 0.05) in all treatments compared to controls, with M0.5 showing the highest values (Fig. 2, Figure 3, Figure 4, Fig. 5). Post-challenge (H+1 to H+14 UT), THC and PO levels increased in all treatments except K-, peaking at H+5, with M0.5 as the highest (P < 0.05), while PO unexpectedly increased in K+ at H+7. By H+14, M0.5, M0.75, and M1 remained significantly higher than K- (P < 0.05) but showed no difference from K+. RB and AF followed a similar trend, peaking at H+5, with M0.5 significantly higher than all treatments (P < 0.05), while RB levels at H+14 showed M1 as the highest. K+ and K- showed no significant difference throughout. These results suggest that Moringa supplementation, particularly at 0.5%, enhances immune parameters in P. vannamei.Fig. 2Total Hemocyte Count (THC) of white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H + 1 UT), day 3 post-challenge (H + 3 UT), day 5 post-challenge (H + 5 UT), day 7 post-challenge (H + 7 UT), and day 14 post-challenge (H + 14 UT). K- (without Moringa leaf powder and not infected with V. parahaemolyticus), K+ (without Moringa leaf powder and infected with V. parahaemolyticus), treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), M1 (1 g kg⁻¹) and infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P < 0.05).Fig 2Figure 3Phenoloxidase (PO) activity of white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H+1 UT), day 3 post-challenge (H+3 UT), day 5 post-challenge (H+5 UT), day 7 post-challenge (H+7 UT), and day 14 post-challenge (H+14 UT). K- (without Moringa leaf powder and not infected with V. parahaemolyticus), K+ (without Moringa leaf powder and infected with V. parahaemolyticus), treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), M1 (1 g kg⁻¹) and infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P<0.05).Figure 3Figure 4Respiratory Burst (RB) activity of white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H+1 UT), day 3 post-challenge (H+3 UT), day 5 post-challenge (H+5 UT), day 7 post-challenge (H+7 UT), and day 14 post-challenge (H+14 UT). K- (without Moringa leaf powder and not infected with V. parahaemolyticus), K+ (without Moringa leaf powder and infected with V. parahaemolyticus), treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), M1 (1 g kg⁻¹) and infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P<0.05).Figure 4Fig. 5Phagocytic Activity (PA) of white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H + 1 UT), day 3 post-challenge (H + 3 UT), day 5 post-challenge (H + 5 UT), day 7 post-challenge (H + 7 UT), and day 14 post-challenge (H + 14 UT). K- (without Moringa leaf powder and not infected with V. parahaemolyticus), K+ (without Moringa leaf powder and infected with V. parahaemolyticus), treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), M1 (1 g kg⁻¹) and infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P < 0.05).Fig 5 Total Hemocyte Count (THC) of white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H + 1 UT), day 3 post-challenge (H + 3 UT), day 5 post-challenge (H + 5 UT), day 7 post-challenge (H + 7 UT), and day 14 post-challenge (H + 14 UT). K- (without Moringa leaf powder and not infected with V. parahaemolyticus), K+ (without Moringa leaf powder and infected with V. parahaemolyticus), treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), M1 (1 g kg⁻¹) and infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P < 0.05). Phenoloxidase (PO) activity of white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H+1 UT), day 3 post-challenge (H+3 UT), day 5 post-challenge (H+5 UT), day 7 post-challenge (H+7 UT), and day 14 post-challenge (H+14 UT). K- (without Moringa leaf powder and not infected with V. parahaemolyticus), K+ (without Moringa leaf powder and infected with V. parahaemolyticus), treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), M1 (1 g kg⁻¹) and infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P<0.05). Respiratory Burst (RB) activity of white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H+1 UT), day 3 post-challenge (H+3 UT), day 5 post-challenge (H+5 UT), day 7 post-challenge (H+7 UT), and day 14 post-challenge (H+14 UT). K- (without Moringa leaf powder and not infected with V. parahaemolyticus), K+ (without Moringa leaf powder and infected with V. parahaemolyticus), treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), M1 (1 g kg⁻¹) and infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P<0.05). Phagocytic Activity (PA) of white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H + 1 UT), day 3 post-challenge (H + 3 UT), day 5 post-challenge (H + 5 UT), day 7 post-challenge (H + 7 UT), and day 14 post-challenge (H + 14 UT). K- (without Moringa leaf powder and not infected with V. parahaemolyticus), K+ (without Moringa leaf powder and infected with V. parahaemolyticus), treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), M1 (1 g kg⁻¹) and infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P < 0.05). Shrimp growth performance The growth performance of white shrimp fed with Moringa leaf powder at 0.5, 0.75, and 1 g/kg using the coating method for 30 days is presented in Table 4. The results showed a significant difference (P < 0.05) in growth rate between all treatments and the control, but no significant difference among treatments. The FCR of M0.5 and M0.75 treatments were significantly higher than M1 and the control (P < 0.05), while M0.5 and M0.75 showed no significant difference, M0.75 also did not differ significantly from M1, whereas M1 and the control showed no significant difference. These findings indicate that Moringa supplementation influences shrimp growth performance, with M0.5 achieving the best FCR (1.44 ± 0.10a) and GR (0.208 ± 0.15).Table 4Growth performance of white shrimp fed with Moringa leaf powder.Table 4ParametersTreatmentK-K+M0,5M0,75M1B0 (g)18,30±0,88a17,75±1,42a17,05±0,31a18,90±0,83a17,65±0,35aBt (g)66,00±4,50a64,00±5,30a111,00±6,60c89,50±3,10b80,55±7,60bAverage Weight (g)4,40±0,30a4,27±0,35a7,40±0,44c5,97±0,21b5,37±0,50bGrowth rate (g day −1)0106±0,11a0103±0,12a0208±0,15c0159±0,01b0139±0,020bFCR2,21±0,22c2,29±0,27c1,44±0,10a1,79±0,85ab1,93±0,23bcNotes: Initial biomass (B0), final biomass (Bt), feed conversion ratio (FCR). The same letters in the same row indicate no significant difference (P < 0.05). The values presented are means and standard deviations. Negative control (K-), positive control (K+), treatment with Moringa leaf powder 0.5 g kg⁻¹ (M0.5), treatment with Moringa leaf powder 0.75 g kg⁻¹ (M0.75), treatment with Moringa leaf powder 1 g kg⁻¹ (M1). Table 4Growth performance of white shrimp fed with Moringa leaf powder.Table 4ParametersTreatmentK-K+M0,5M0,75M1B0 (g)18,30±0,88a17,75±1,42a17,05±0,31a18,90±0,83a17,65±0,35aBt (g)66,00±4,50a64,00±5,30a111,00±6,60c89,50±3,10b80,55±7,60bAverage Weight (g)4,40±0,30a4,27±0,35a7,40±0,44c5,97±0,21b5,37±0,50bGrowth rate (g day −1)0106±0,11a0103±0,12a0208±0,15c0159±0,01b0139±0,020bFCR2,21±0,22c2,29±0,27c1,44±0,10a1,79±0,85ab1,93±0,23bcNotes: Initial biomass (B0), final biomass (Bt), feed conversion ratio (FCR). The same letters in the same row indicate no significant difference (P < 0.05). The values presented are means and standard deviations. Negative control (K-), positive control (K+), treatment with Moringa leaf powder 0.5 g kg⁻¹ (M0.5), treatment with Moringa leaf powder 0.75 g kg⁻¹ (M0.75), treatment with Moringa leaf powder 1 g kg⁻¹ (M1). Growth performance of white shrimp fed with Moringa leaf powder. Notes: Initial biomass (B0), final biomass (Bt), feed conversion ratio (FCR). The same letters in the same row indicate no significant difference (P < 0.05). The values presented are means and standard deviations. Negative control (K-), positive control (K+), treatment with Moringa leaf powder 0.5 g kg⁻¹ (M0.5), treatment with Moringa leaf powder 0.75 g kg⁻¹ (M0.75), treatment with Moringa leaf powder 1 g kg⁻¹ (M1). Expression of Immune-related Genes in Shrimp LGBP, PE, and SP gene expression were measured at H0, H1-UT, and H7-UT. At H0, M0.5 had the highest LGBP (2.66 ± 0.05, P < 0.05) and SP (3.59 ± 0.38, P < 0.05) expression, while PE showed no significant differences (Fig. 6, Figure 7, Fig. 8). At H1-UT, expression increased across all treatments, with M0.5 consistently exhibiting the highest levels: LGBP (8.23 ± 0.41), PE (15.62 ± 0.30), and SP (12.82 ± 0.38) (P < 0.05). By H7-UT, expression declined in all groups, but M0.5 remained the highest for LGBP (6.52 ± 0.03), PE (8.09 ± 0.23), and SP (5.57 ± 0.47) (P < 0.05). Overall, M0.5 consistently showed the highest gene expression across all time points.Fig. 6The relative gene expression of LGBP in white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H1-UT), and on day 7 post-challenge (H7-UT). K+ (without Moringa leaf powder and infected with V. parahaemolyticus), and treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), and M1 (1 g kg⁻¹), then infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P < 0.05).Fig 6Figure 7The relative gene expression of PE in white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H1-UT), and on day 7 post-challenge (H7-UT). K+ (without Moringa leaf powder and infected with V. parahaemolyticus), and treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), and M1 (1 g kg⁻¹), then infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P<0.05).Figure 7Fig. 8The relative gene expression of SP in white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H1-UT), and on day 7 post-challenge (H7-UT). K+ (without Moringa leaf powder and infected with V. parahaemolyticus), and treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), and M1 (1 g kg⁻¹), then infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P < 0.05).Fig 8 The relative gene expression of LGBP in white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H1-UT), and on day 7 post-challenge (H7-UT). K+ (without Moringa leaf powder and infected with V. parahaemolyticus), and treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), and M1 (1 g kg⁻¹), then infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P < 0.05). The relative gene expression of PE in white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H1-UT), and on day 7 post-challenge (H7-UT). K+ (without Moringa leaf powder and infected with V. parahaemolyticus), and treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), and M1 (1 g kg⁻¹), then infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P<0.05). The relative gene expression of SP in white shrimp before treatment (H0), before the challenge test (H30), on day 1 post-challenge (H1-UT), and on day 7 post-challenge (H7-UT). K+ (without Moringa leaf powder and infected with V. parahaemolyticus), and treatment groups fed with Moringa leaf powder for 30 days: M0.5 (0.5 g kg⁻¹), M0.75 (0.75 g kg⁻¹), and M1 (1 g kg⁻¹), then infected with V. parahaemolyticus. Different letters above the bar diagram indicate significant differences (P < 0.05). Discussion Vibriosis is a disease caused by pathogenic bacteria such as V. alginolyticus, V. splendidus, V. harveyi, and V. parahaemolyticus [8]. Among these, V. parahaemolyticus is particularly significant as it also causes Acute Hepatopancreatic Necrosis Disease (AHPND), a condition linked to strains carrying the Photorhabdus insect-related (Pir) toxin genes, PirA and PirB, which are responsible for extensive tissue damage in the hepatopancreas and high mortality in shrimp populations [[15], [16]]. Recent studies have also revealed that Vibrio species are dominant members of bacterial communities in shrimp culture systems, suggesting that their abundance and composition in pond environments are closely linked to disease emergence and shrimp health [13]. This dominance is often associated with microbial dysbiosis, where the imbalance between beneficial and pathogenic bacteria promotes the proliferation of virulent Vibrio. These bacteria are responsible for several major diseases which collectively contribute to substantial economic losses in shrimp aquaculture, particularly in Asia. Moreover, the ability of Vibrio spp. to form biofilms, secrete virulence factors, and establish synergistic interactions with other pathogens further complicates disease management and underscores the importance of maintaining microbial balance and environmental stability to ensure shrimp health and culture sustainability [13,43]. In this study, dietary supplementation with Moringa leaf powder in feed demonstrated a significant reduction of bacterial infections attributable to V. parahaemolyticus, likely due to its high content of bioactive phytochemicals such as flavonoids, tannins, and steroids. In our assay, moringa leaf powder produced inhibition zones of 11.00–15.83 mm against V. parahaemolyticus; higher moringa concentrations corresponded to greater antibacterial activity. Kenconojati et al. (2023) [26] reported that V. parahaemolyticus is more susceptible to moringa extract than V. harveyi, suggesting species-specific sensitivity to the phytochemicals (flavonoids, polyphenols, terpenoids, steroids, saponins, tannins). Phytochemicals such as flavonoids disrupt bacterial cell membranes and induce lysis [45], while tannins interfere with cell-wall formation and enzyme function [46], and steroids compromise membrane integrity causing cell lysis [47]. Such findings align with recent work by Abidin et al. (2022) [28], who reported that water extract of M. oleifera leaves enhanced total hemocyte count (THC), phenoloxidase (PO) activity, phagocytosis rate and superoxide anion production in white shrimp, resulting in improved survival after challenge with V. alginolyticus [48]. Moreover, a combined study of moringa extract and Lactobacillus acidophilus showed improved intestinal microbiota, enzyme activity, histology, and disease resistance against both V. alginolyticus and V. parahaemolyticus in white shrimp [28]. Moringa leaf powder supplementation at 0.5, 0.75, and 1 g/kg in shrimp feed improved survival rates (69.33–86.67 %) post-infection compared to 44.33 % in the control group. While no significant differences were found among treated groups, all showed significantly higher survival than the untreated group (P < 0.05). Lower moringa doses may minimize the cytotoxic effects of tannins, which can enhance immunity at low doses but become cytotoxic at high concentrations [49]. Arisa et al. (2019) [50], showed that immersion of shrimp in 1000 ppm Moringa extract improved survival to 91 % following Vibrio challenge. However, excessive exposure to plant polyphenols has been reported to induce hepatotoxicity and reduce digestive enzyme activity in fish [51]. Moringa supplementation also enhanced non-specific immune responses in shrimp post-infection, attributed to bioactive compounds boosting Total Hemocyte Count (THC), phenoloxidase (PO) activity, respiratory burst (RB), and phagocytic activity (PA). Similar findings were reported by Abidin et al. (2021) [27], where moringa extract enhanced shrimp immunity against V. alginolyticus. Dewi et al. (2021) [52], demonstrated that phytochemicals in guava leaves, such as flavonoids and saponins, also boosted shrimp immunity against V. parahaemolyticus. THC analysis showed significant increases in moringa-treated shrimp compared to the control. The highest THC (38 × 105 cells/mL) was observed in the 0.5 g/kg group on day 5 post-infection, compared to 13 × 105 cells/mL in the untreated group. Other moringa-treated groups (0.75 and 1 g/kg) also had elevated THC levels (36 × 105 and 35 × 105 cells/mL, respectively). Hemocytes play a crucial role in cellular and humoral immune responses [53]. Feeding shrimp moringa powder for 30 days enhanced immune responses and hemocyte production post-infection, indicating its potential as a natural antibacterial and immunostimulant. From an immunological perspective, the groups supplemented with Moringa showed higher lysozyme and respiratory burst activity, which are critical for innate defense against Gram-negative bacteria such as Vibrio. These responses are likely mediated by Moringa-derived bioactives, including flavonoids (quercetin, kaempferol) and phenolic acids, known to modulate macrophage and neutrophil activity [54]. The results of this study demonstrate the immunostimulant potential of Moringa leaf powder, which significantly enhances the expression of immune-related genes in shrimp, specifically LGBP, SP, and PE, before the challenge test, on day 1 post-challenge (H1-UT), and on day 7 post-challenge (H7-UT). Observations on immune-related gene expression confirm the influence of phytochemical compounds present in Moringa leaf powder, such as phenolic acids, flavonoids, carotenoids, lectins, and tannins [55]. The lectins contained in Moringa leaves play an essential role in enhancing immunostimulant activity, functioning as lectin-like receptors (LLRs) and toll-like receptors (TLRs). Lectins consist of amino acid compounds that can form polysaccharides, contributing to the immune response enhancement in white shrimp [56]. According to Tassanakajon et al. (2013) [57]. proteins serve as receptors that recognize pathogens, and in shrimp, one such protein is Lipopolysaccharide and beta-1,3-glucan binding protein (LGBP). LGBP has a molecular weight of 30–45 kDa and is synthesized in shrimp hemocytes, where it becomes actively regulated upon infection by Gram-negative bacteria. The primary function of LGBP in shrimp is to recognize and respond to invading bacterial pathogens.LGBP binds to ligands, which then activate the prophenoloxidase (proPO) system [34]. Phenoloxidase (PO) is the active form of prophenoloxidase (proPO), which is activated by serine protease (SP) [42]. PO releases melanin as a final product, which can inactivate and prevent the spread of pathogens ([58]. Peroxinectin (PE) is a cell adhesion protein involved in encapsulation, peroxidase activity, and degranulation [19]. According to Liu et al. (2005) [59], increased PE expression correlates with phagocytic activity, which serves as the primary immune defense mechanism against pathogens and is activated upon pathogen entry into the shrimp's body [59]. In this study, overall and compared to the control, Moringa had no effect on water quality because it was administered in small amounts through feed, resulting in no significant differences in water quality during the rearing period. Furthermore, several studies reported that dietary or waterborne application of Moringa did not adversely affect water quality parameters such as dissolved oxygen, pH, and ammonia levels, indicating that its use as a feed additive or immunostimulant is environmentally safe [22,[60], [61]]. Conclusion This study demonstrates that oral supplementation with Moringa leaf powder enhances survival, immune response, and the expression of key immune-related genes (LGBP, SP, and PE) in Pacific white shrimp challenged with V. parahaemolyticus. Among the tested doses, 0.5 g/kg proved to be the most effective, significantly improving both immunity and growth performance. The immunostimulatory effects of Moringa are attributed to its bioactive compounds, including lectins, flavonoids, and phenolic acids, which enhance immune activation. These findings highlight Moringa leaf powder as a promising natural alternative to antibiotics for disease prevention in shrimp aquaculture. However, further studies are needed to evaluate its long-term effects, optimize dosing strategies, and elucidate the underlying molecular mechanisms involved in its immunomodulatory properties. Funding This work was supported by grants from the Directorate of Research and Community Service, Directorate General of Research and Development, Ministry of Education, Culture, Research and Technology of the Republic of Indonesia with contract number 027/E5/PG.02.00.PL/2024. Ethics approval This research has been also approved by the animal ethics commission of the IPB University veterinary and biomedical school, with registration number: 123/KEH/SKE/X/2023. Consent to participate All authors consented to participate in all aspects of this study and publication. Code availability Not applicable. CRediT authorship contribution statement Sri Nuryati: Writing – review & editing, Validation, Supervision, Methodology, Investigation, Funding acquisition, Formal analysis, Conceptualization. Dika Nur Setiyawan: Writing – original draft, Visualization, Software, Methodology, Data curation, Conceptualization. Munti Yuhana: Writing – review & editing, Validation, Supervision, Methodology, Investigation, Conceptualization. Muhamad Gustilatov: Writing – review & editing, Visualization, Validation, Supervision, Formal analysis. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.